PubRank

Felix Bock

Author PubWeight™ 20.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol 2009 1.97
2 GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology 2009 1.67
3 Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol 2007 1.29
4 Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol 2008 1.27
5 Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009 1.18
6 Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. J Exp Med 2011 1.10
7 Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol 2011 1.00
8 Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman. Lymphat Res Biol 2008 1.00
9 Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs. Cornea 2012 0.96
10 Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels. PLoS One 2011 0.96
11 Genetic heterogeneity of lymphangiogenesis in different mouse strains. Am J Pathol 2010 0.93
12 Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. J Immunol 2010 0.92
13 Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation. Invest Ophthalmol Vis Sci 2008 0.91
14 Recurrent interface abscess secondary to Acanthamoeba keratitis treated by deep anterior lamellar keratoplasty. Int J Ophthalmol 2012 0.84
15 Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis. Acta Ophthalmol 2012 0.82
16 Central corneal epithelium self-healing after ring-shaped glycerin-cryopreserved lamellar keratoplasty in Terrien marginal degeneration. Int J Ophthalmol 2013 0.79
17 Corneal angiogenesis and lymphangiogenesis. Curr Opin Allergy Clin Immunol 2012 0.78
18 Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis. Invest Ophthalmol Vis Sci 2011 0.78
19 Short- and long-term corneal vascular effects of tafluprost eye drops. Graefes Arch Clin Exp Ophthalmol 2013 0.76
20 Short-Term Ultraviolet A Irradiation Leads to Dysfunction of the Limbal Niche Cells and an Antilymphangiogenic and Anti-inflammatory Micromilieu. Invest Ophthalmol Vis Sci 2016 0.76
21 Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo. Invest Ophthalmol Vis Sci 2013 0.75
22 Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis. Graefes Arch Clin Exp Ophthalmol 2014 0.75